Coldstream Labs to expand formulation and analytical development facilities.
LEXINGTON, KY (May 6, 2011) – Coldstream Laboratories, Inc. today announced an expansion of its formulation and analytical development facilities at the Coldstream Research Campus in Lexington. The expansion includes the addition of workspace for new staff the company has added over the last several months. Additionally, the company has invested in a second laboratory scale freeze dryer that will expand the company’s capacity to develop lyophilized drug products.
“The addition of the new laboratory space is consistent with our growth strategy,” said Coldstream’s CEO, Larry Kranking. “We have experienced significant growth in demand for development of injectable drugs over the last six months and have been adding new talent to our laboratory staff. We chose to expand our laboratory space to make way for this growth and to allow us to continue to execute on our strategic plan.”
Coldstream is in the process of expanding its laboratory staff by approximately 25 percent at its Lexington facilities. Most of the new positions are to be filled with formulation scientists and analytical chemists.
Coldstream Laboratories, Inc. is a specialty manufacturer of sterile injectable drugs and operates Kentucky’s only sterile pharmaceutical manufacturing facility.